Thus, the dual inhibition of glutaminolysis and glycolysis by combined treatment with miR-634 ointment and a TKI is a reasonable strategy for improving the efficacy of EGFR TKIs in cSCC. Here, EGFR is linked to skin squamous cell carcinoma.